A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine

Vaccine

Volumn 26, Issue 26, 2008, Pages 3332-3340

  Gregersen, Jens Peter ^a  

^a Novartis Behring   (Germany)

Author keywords

Influenza vaccine; MDCK cells; Viral safety

Indexed keywords

INFLUENZA VACCINE;

ANIMAL CELL; ARTICLE; CELL STRAIN; CHICK EMBRYO; DRUG FORMULATION; EMBRYO; INFECTION RISK; INFLUENZA VACCINATION; NONHUMAN; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RISK ASSESSMENT; RISK REDUCTION; VACCINE PRODUCTION; VIRAL CONTAMINATION; VIROGENESIS; VIRUS CULTURE; VIRUS ISOLATION; VIRUS STRAIN;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE; DOGS; DRUG CONTAMINATION; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE; RISK ASSESSMENT; VACCINES, SUBUNIT;

EID: 44749090301     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.03.075     Document Type: Article

References (29)

1. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2007-2008 northern hemisphere influenza season. 2007 (http://www.who.int/csr/disease/influenza/recommendations2007north/en/index.html. Accessed March 20, 2008).
2. Gerdil C. The annual production cycle for influenza vaccine. Vaccine 21 (2003) 1776-1779
3. Nichol K.L. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 21 (2003) 1769-1775
4. Ulmer J.B., Valley U., and Rappuoli R. Vaccine manufacturing: challenges and solutions. Nat Biotechnol 24 (2006) 1377-1383
5. Poland G.A., Jacobson R.M., and Targonski P.V. Avian and pandemic influenza: an overview. Vaccine 25 (2007) 3057-3061
6. Zimmerman R.K. Recent changes in influenza vaccination recommendations 2007. J Fam Pract 56 2 Suppl. Vaccines (2007) S61-S69
7. Govorkova E.A., Kodihalli S., Alymova I.V., Fanget B., and Webster R.G. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs. Dev Biol Stand 98 (1999) 39-51
8. Brands R., Visser J., Medema J., Palache A.M., and van Scharrenburg G.J.M. Influvac: a safe Madin-Darby Canine Kidney (MDCK) cell culture-based influenza vaccine. Dev Biol Stand 98 (1999) 93-100
9. Mabrouk T., and Ellis R.W. Influenza vaccine technologies and the use of cell-culture processes (cell-culture influenza vaccine). Dev Biol (Basel) 110 (2002) 125-134
10. Oxford J.S., Manuguerra C., Kistner O., Linde A., Kunze M., Lange W., et al. A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines. Vaccine 23 (2005) 5440-5449
11. Harasawa R., and Tomiyama T. Evidence of pestivirus RNA in human virus vaccines. J Clin Microbiol 32 (1994) 1604-1605
12. Krause P.R. Adventitious agents and vaccines. Emerg Infect Dis 7 (2001) 562
13. Wiselka M.J. Vaccine safety. In: Nicholson K.G., Webster R.G., and Hay A.J. (Eds). Textbook of influenza (1998), Blackwell Science, Oxford 346-357
14. Madin SH, Darby NB. Appendix VIII. Tech Prog Rep, 25. California: Naval Biological Laboratory; 1958, p. 276.
15. Food and Drug Administration. International Conference on Harmonisation; guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin; availability-FDA Notice. Fed Regist 63 (1998) 51074-51084
16. Frank A.L., Couch R.B., Griffis C.A., and Baxter B.D. Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses. J Clin Microbiol 10 (1979) 32-36
17. Montgomery L.B., Kao C.Y., Verdin E., Cahill C., and Maratos-Flier E. Infection of a polarized epithelial cell line with wild-type reovirus leads to virus persistence and altered cellular function. J Gen Virol 72 (1991) 2939-2946
18. Hayashi K. Role of tight junctions of polarized epithelial MDCK cells in the replication of herpes simplex virus type 1. J Med Virol 47 (1995) 323-329
19. Reina J., Ballesteros F., Mari M., and Munar M. Evaluation of different continuous cell lines in the isolation of mumps virus by the shell vial method from clinical samples. J Clin Pathol 54 (2001) 924
20. Imagawa D.T., Baird C.D., and Adams J.M. Growth of two Morbilliviruses, measles/Edmonston and canine distemper virus in MDCK cells. J M Fed Proc 22 (1963) 488
21. Maisner A., Klenk H.-D., and Herrler G. Polarized budding of measles virus is not determined by viral surface glycoproteins. J Virol 72 (1998) 5276-5278
22. Shih S.R., Tsao K.C., Ning H.C., Huang Y.C., and Lin T.Y. Diagnosis of respiratory tract viruses in 24 h by immunofluorescent staining of shell vial cultures containing MDCK cells. J Virol Methods 81 (1999) 77-81
23. Shinjoh M., Omoe K., Saito N., Matsuo N., and Nerome K. In vitro growth profiles of respiratory syncytial virus in the presence of influenza virus. Acta Virol 44 (2000) 91-97
24. Zavattoni M., Percivalle E., Cattaneo E., Revello M.G., Torsellini M., and Gerna G. Optimized detection of respiratory viruses in nasopharyngeal secretions. New Microbiol 26 (2003) 133-140
25. Sahu S.P., and Olson N.O. Comparison and characteristics of avian reovirus isolated from the digestive and respiratory tract with virus isolated from the synovia. Am J Vet Res 36 (1975) 847-850
26. Barta V., Springer W.T., and Millar D.L. A comparison of avian and mammalian cell cultures for the propagation of avian reovirus WVU 2937. Avian Dis 28 (1984) 216-223
27. In: Rolle M., and Mayr A. (Eds). Medizinische Mikrobiologie, Infektions-und Seuchenlehre Enke Verlag. 4th ed. (1978), Enke Verlag, Stuttgart
28. In: Rolle M., and Mayr A. (Eds). Medizinische Mikrobiologie, Infektions-und Seuchenlehre Enke Verlag. 7th ed. (2002), Enke Verlag, Stuttgart
29. Garnick R.L. Experience with viral contamination in cell culture. Dev Biol Stand 88 (1996) 49-56